12:00 AM
Nov 09, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ChondroCelect: Additional Phase III data

Additional data from a European Phase III trial in 118 patients showed that ChondroCelect was superior to microfracture, the standard of care for symptomatic cartilage defects, in clinical outcome as measured by overall knee injury and osteoarthritis...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >